Radiomics in Kidney Cancer: MR Imaging.

Renal tumors encompass a heterogeneous disease spectrum, which confounds patient management and treatment. Percutaneous biopsy is limited by an inability to sample every part of the tumor. Radiomics may provide detail beyond what can be achieved from human interpretation. Understanding what new technologies offer will allow radiologists to play a greater role in caring for patients with renal cell carcinoma. In this article, we review the use of radiomics in renal cell carcinoma, in both the pretreatment assessment of renal masses and posttreatment evaluation of renal cell carcinoma, with special emphasis on the use of multiparametric MR imaging datasets.

[1]  Chandru P Sundaram,et al.  Usefulness of diffusion-weighted imaging in the evaluation of renal masses. , 2010, AJR. American journal of roentgenology.

[2]  Scott B Reeder,et al.  Water–fat separation with IDEAL gradient‐echo imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[3]  K. Flaherty,et al.  Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma , 2008, Cancer biology & therapy.

[4]  H. Hricak,et al.  Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. , 2013, Radiology.

[5]  P. Pickhardt,et al.  CT Textural Analysis of Large Primary Renal Cell Carcinomas: Pretreatment Tumor Heterogeneity Correlates With Histologic Findings and Clinical Outcomes. , 2016, AJR. American journal of roentgenology.

[6]  P. Lo,et al.  Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. , 2017, AJR. American journal of roentgenology.

[7]  N. Rofsky,et al.  Magnetic resonance imaging as a biomarker in renal cell carcinoma , 2009, Cancer.

[8]  J. Cadeddu,et al.  Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. , 2016, Clinical genitourinary cancer.

[9]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[10]  N. Palanisamy,et al.  Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database , 2017, Modern Pathology.

[11]  W. Shabana,et al.  Diagnosis of Sarcomatoid Renal Cell Carcinoma With CT: Evaluation by Qualitative Imaging Features and Texture Analysis. , 2015, AJR. American journal of roentgenology.

[12]  B. Ljungberg,et al.  Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention , 2010, World Journal of Urology.

[13]  Baris Turkbey,et al.  Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI , 2017, Scientific Reports.

[14]  Aitao Guo,et al.  Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. , 2010, Radiology.

[15]  Hugo J W L Aerts,et al.  Data Science in Radiology: A Path Forward , 2017, Clinical Cancer Research.

[16]  Ivan Pedrosa,et al.  Magnetic Resonance Imaging–Measured Blood Flow Change after Antiangiogenic Therapy with PTK787/ZK 222584 Correlates with Clinical Outcome in Metastatic Renal Cell Carcinoma , 2008, Clinical Cancer Research.

[17]  Hersh Chandarana,et al.  Subtype Differentiation of Renal Tumors Using Voxel-Based Histogram Analysis of Intravoxel Incoherent Motion Parameters , 2015, Investigative radiology.

[18]  Berthold Kiefer,et al.  Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. , 2012, Radiology.

[19]  Y. Kanai,et al.  Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma , 2016, Scientific Reports.

[20]  Matthew A. Zapala,et al.  The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma. , 2015, Radiology.

[21]  George M Yousef,et al.  Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study , 2012, Laboratory Investigation.

[22]  J. Cadeddu,et al.  Development of a Patient-specific Tumor Mold Using Magnetic Resonance Imaging and 3-Dimensional Printing Technology for Targeted Tissue Procurement and Radiomics Analysis of Renal Masses. , 2018, Urology.

[23]  Erich P Huang,et al.  Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas–Renal Cell Carcinoma (TCGA–RCC) Imaging Research Group , 2015, Abdominal Imaging.

[24]  Francesca Demichelis,et al.  Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. , 2007, Human pathology.

[25]  S. Schoenberg,et al.  Diffusion-weighted imaging of focal renal lesions: a meta-analysis , 2013, European Radiology.

[26]  Xiangyu Yang,et al.  Quantifying Tumor Vascular Heterogeneity with Dynamic Contrast-Enhanced Magnetic Resonance Imaging: A Review , 2011, Journal of biomedicine & biotechnology.

[27]  Perry J Pickhardt,et al.  CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[28]  Jinzhong Yang,et al.  Measuring Computed Tomography Scanner Variability of Radiomics Features , 2015, Investigative radiology.

[29]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[30]  I. Pedrosa,et al.  MRI Phenotype in Renal Cancer: Is It Clinically Relevant? , 2014, Topics in magnetic resonance imaging : TMRI.

[31]  R. Ehman,et al.  Magnetic resonance elastography of liver: Technique, analysis, and clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.

[32]  Philippe Lambin,et al.  Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures , 2017, The British journal of radiology.

[33]  Andre Dekker,et al.  A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[35]  J. Buckner,et al.  MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas , 2016, Medical physics.

[36]  Hersh Chandarana,et al.  Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. , 2010, AJR. American journal of roentgenology.

[37]  Ivan Pedrosa,et al.  Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. , 2009, Radiology.

[38]  J. Hennig,et al.  PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. , 2002, Cancer research.

[39]  J. Copland,et al.  Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma , 2013, Clinical Cancer Research.

[40]  M. Griswold,et al.  Vascular Tumor Burden as a New Quantitative CT Biomarker for Predicting Metastatic RCC Response to Antiangiogenic Therapy. , 2016, Radiology.

[41]  A. Horiguchi,et al.  Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. , 2008, The Journal of urology.

[42]  Lisa N Kinch,et al.  Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes , 2014, Nature Genetics.

[43]  R. Lenkinski,et al.  Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? , 2009, Radiology.

[44]  J. Cadeddu,et al.  Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity. , 2016, Clinical genitourinary cancer.

[45]  B. Leibovich,et al.  Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. , 2012, Radiology.

[46]  T Sasaki,et al.  Perfusion Imaging of Brain Tumors Using Arterial Spin-Labeling: Correlation with Histopathologic Vascular Density , 2008, American Journal of Neuroradiology.

[47]  Bachir Taouli,et al.  Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. , 2009, Radiology.

[48]  Ivan Pedrosa,et al.  MR techniques for renal imaging. , 2003, Radiologic clinics of North America.

[49]  D. Sullivan,et al.  A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. , 2011, Radiology.

[50]  R. Deberardinis,et al.  Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI. , 2017, JCI insight.

[51]  V. Goh,et al.  Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.